Feedback / Questions
AIC100 - AffyImmune Therap
https://www.businesswire.com/news/home/20240409036952/en/AffyImmune-Presents-Preclinical-Data-on-AIC100-Affinity-Tuned-CAR-T-Targeting-ICAM-1-in-Additional-Solid-Tumor-Types-at-AACR-2024/
Apr 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next